On the public citation graph
Optimization of Imidazo[4,5-b]pyridine-Based Kinase Inhibitors: Identification of a Dual FLT3/Aurora Kinase Inhibitor as an Orally Bioavailable Preclinical Development Candidate for the Treatment of Acute Myeloid Leukemia
0 signed · 134 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/chin.200127235openalex-snapshot
ChemInform Abstract: Property‐Based Design: Optimization of Drug Absorption and Pharmacokinetics
inferredcites →https://doi.org/10.1016/j.beha.2010.09.008openalex-snapshot
Will newer tyrosine kinase inhibitors have an impact in AML?
inferredcites →https://doi.org/10.1016/j.bmcl.2006.12.061openalex-snapshot
A quantitative assessment of hERG liability as a function of lipophilicity
inferredcites →https://doi.org/10.1016/j.bmcl.2007.09.076openalex-snapshot
Hit generation and exploration: Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases
inferredcites →https://doi.org/10.1016/j.bmcl.2007.11.080openalex-snapshot
1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity
inferredcites →https://doi.org/10.1016/j.bmcl.2010.08.091openalex-snapshot
Structure-based design of imidazo[1,2-a]pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells
inferredcites →https://doi.org/10.1016/j.molcel.2005.03.031openalex-snapshot
Mechanism of Aurora B Activation by INCENP and Inhibition by Hesperadin
inferredcites →https://doi.org/10.1016/j.yexcr.2004.08.016openalex-snapshot
Aurora kinases in spindle assembly and chromosome segregation
inferredcites →https://doi.org/10.1016/s1097-2765(03)00392-7openalex-snapshot
Structural Basis of Aurora-A Activation by TPX2 at the Mitotic Spindle
inferredcites →https://doi.org/10.1021/ci700018yopenalex-snapshot
New and Original pKa Prediction Method Using Grid Molecular Interaction Fields
inferredcites →https://doi.org/10.1021/jm000407eopenalex-snapshot
Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics
inferredcites →https://doi.org/10.1021/jm00334a001openalex-snapshot
A Mathematical Contribution to Structure-Activity Studies
inferredcites →https://doi.org/10.1021/jm049424kopenalex-snapshot
Cationic Chalcone Antibiotics. Design, Synthesis, and Mechanism of Action
inferredcites →https://doi.org/10.1021/jm060379lopenalex-snapshot
Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups
inferredcites →https://doi.org/10.1021/jm060897wopenalex-snapshot
1,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazoles: Identification of a Potent Aurora Kinase Inhibitor with a Favorable Antitumor Kinase Inhibition Profile
inferredcites →https://doi.org/10.1021/jm061335fopenalex-snapshot
Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase
inferredcites →https://doi.org/10.1021/jm100262jopenalex-snapshot
Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidate
inferredcites →https://doi.org/10.1021/jm8012129openalex-snapshot
Discovery and Development of Aurora Kinase Inhibitors as Anticancer Agents
inferredcites →https://doi.org/10.1021/jm900002xopenalex-snapshot
Side Chain Flexibilities in the Human Ether-a-go-go Related Gene Potassium Channel (hERG) Together with Matched-Pair Binding Studies Suggest a New Binding Mode for Channel Blockers
inferredcites →https://doi.org/10.1023/b:neon.0000021784.33421.05openalex-snapshot
High Expression of Aurora-B/Aurora and Ipl1-Like Midbody-Associated Protein (AIM-1) in Astrocytomas
inferredcites →https://doi.org/10.1038/leu.2010.15openalex-snapshot
Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias
inferredcites →https://doi.org/10.1038/leu.2012.52openalex-snapshot
Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
inferredcites →https://doi.org/10.1038/nbt1068openalex-snapshot
A small molecule–kinase interaction map for clinical kinase inhibitors
inferredcites →https://doi.org/10.1038/nbt1358openalex-snapshot
A quantitative analysis of kinase inhibitor selectivity
inferredcites →https://doi.org/10.1038/nm1003openalex-snapshot
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
inferredcites →https://doi.org/10.1038/nrc1169openalex-snapshot
The role of FLT3 in haematopoietic malignancies
inferredcites →https://doi.org/10.1038/nrm1245openalex-snapshot
The cellular geography of Aurora kinases
inferredcites →https://doi.org/10.1038/sj.bjc.6605642openalex-snapshot
Guidelines for the welfare and use of animals in cancer research
inferredcites →https://doi.org/10.1055/s-2004-834926openalex-snapshot
A Versatile Method for the Synthesis of Benzimidazoles from o-Nitroanilines and Aldehydes in One Step via a Reductive Cyclization
inferredcites →https://doi.org/10.1073/pnas.0608798104openalex-snapshot
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
inferredcites →https://doi.org/10.1074/jbc.274.11.7334openalex-snapshot
Cell Cycle-dependent Expression and Centrosome Localization of a Third Human Aurora/Ipl1-related Protein Kinase, AIK3
inferredcites →https://doi.org/10.1074/jbc.c200307200openalex-snapshot
Phosphorylation of the Carboxyl Terminus of Inner Centromere Protein (INCENP) by the Aurora B Kinase Stimulates Aurora B Kinase Activity
inferredcites →https://doi.org/10.1083/jcb.152.4.669openalex-snapshot
Drosophila Aurora B Kinase Is Required for Histone H3 Phosphorylation and Condensin Recruitment during Chromosome Condensation and to Organize the Central Spindle during Cytokinesis
inferredcites →https://doi.org/10.1093/emboj/17.11.3052openalex-snapshot
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
inferredcites →https://doi.org/10.1107/s0907444902016657openalex-snapshot
PHENIX : building new software for automated crystallographic structure determination
inferredcites →https://doi.org/10.1107/s0907444994003112openalex-snapshot
The CCP4 suite: programs for protein crystallography
inferredcites →https://doi.org/10.1158/0008-5472.can-10-3001openalex-snapshot
Preclinical Evaluation of AMG 900, a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines
inferredcites →https://doi.org/10.1158/1078-0432.ccr-07-2179openalex-snapshot
Aurora Kinases as Anticancer Drug Targets
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-1123openalex-snapshot
Structural and Functional Alterations of FLT3 in Acute Myeloid Leukemia
inferredcites →https://doi.org/10.1158/1535-7163.mct-07-0067openalex-snapshot
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia
inferredcites →https://doi.org/10.1158/1535-7163.mct-07-0444openalex-snapshot
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer
inferredcites →https://doi.org/10.1158/1535-7163.mct-07-2156openalex-snapshot
Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological activity
inferredcites →https://doi.org/10.1158/1535-7163.targ-11-b74openalex-snapshot
Abstract B74: The dual FLT3-Aurora inhibitor CCT241736 overcomes resistance to selective FLT3 inhibition driven by FLT3 ligand and FLT3 point mutations in acute myeloid leukemia.
inferredcites →https://doi.org/10.1159/000350110openalex-snapshot
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
inferredcites →https://doi.org/10.1182/blood-2006-03-009233openalex-snapshot
Clinical implications of FLT3 mutations in pediatric AML
inferredcites →https://doi.org/10.1182/blood-2006-05-024018openalex-snapshot
Activation mechanisms of STAT5 by oncogenic Flt3-ITD
inferredcites →https://doi.org/10.1182/blood-2007-07-099325openalex-snapshot
Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia
inferredcites →https://doi.org/10.1182/blood-2008-06-164889openalex-snapshot
Aurora-A kinase: a novel target of cellular immunotherapy for leukemia
inferredcites →https://doi.org/10.1182/blood-2010-04-261867openalex-snapshot
FLT3 as a therapeutic target in AML: still challenging after all these years
inferredcites →https://doi.org/10.1182/blood.v96.12.3907openalex-snapshot
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways
inferredcites →https://doi.org/10.1210/jc.2004-1518openalex-snapshot
Aurora B Overexpression Associates with the Thyroid Carcinoma Undifferentiated Phenotype and Is Required for Thyroid Carcinoma Cell Proliferation
inferredcites →https://doi.org/10.1242/jcs.013136openalex-snapshot
Aurora-A: the maker and breaker of spindle poles
inferredcites →https://doi.org/10.1517/13543776.2011.574614openalex-snapshot
Aurora kinase inhibitor patents and agents in clinical testing: an update (2009 – 10)
inferredcites →https://doi.org/10.1517/13543776.2014.931374openalex-snapshot
Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 – 2013)
inferredcites →https://doi.org/10.1517/17460441.2011.555395openalex-snapshot
Update on aurora kinase targeted therapeutics in oncology
inferredcites →https://doi.org/10.1677/joe.0.1810263openalex-snapshot
Aurora B expression in normal testis and seminomas
inferredcites →https://doi.org/10.2174/156802608785700061openalex-snapshot
Ligand Structural Aspects of hERG Channel Blockade
inferredcites →https://doi.org/10.3324/haematol.12148openalex-snapshot
Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts
inferredcites →https://doi.org/10.3892/or.10.5.1275openalex-snapshot
The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4875581openalex-extracted
Exploration De L'Ouverture Du Pyranopyrazole Pour La Synthèse De Dérivés Pyrazoliques: Conception, Synthèse, Amarrage Moléculaire, Simulation Dynamique Moléculaire Et Analyses Dft
inferred← citeshttps://doi.org/10.1002/adsc.201400465openalex-snapshot
An Improved Synthesis of Imidazo[4,5‐b]pyridines and Imidazo[4,5‐b]pyrazines by Palladium Catalyzed Amidation using Xantphos in a 1,4‐Dioxane:tert‐Amyl Alcohol Solvent System
inferred← citeshttps://doi.org/10.1002/cbdv.71267openalex-snapshot
Dual‐Targeting Strategy in Cancer Therapy: The Emerging Role of Pyrrolopyrimidine Scaffolds
inferred← citeshttps://doi.org/10.1002/cem.2741openalex-snapshot
High‐dimensional QSAR prediction of anticancer potency of imidazo[4,5‐b]pyridine derivatives using adjusted adaptive LASSO
inferred← citeshttps://doi.org/10.1002/cmdc.201300384openalex-snapshot
Discovery of 7‐Aryl‐Substituted (1,5‐Naphthyridin‐4‐yl)ureas as Aurora Kinase Inhibitors
inferred← citeshttps://doi.org/10.1002/cmdc.201300571openalex-snapshot
Facile Identification of Dual FLT3–Aurora A Inhibitors: A Computer‐Guided Drug Design Approach
inferred← citeshttps://doi.org/10.1002/pbc.26351openalex-snapshot
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia
inferred← citeshttps://doi.org/10.1002/slct.201700969openalex-snapshot
Copper(I)‐Catalyzed Regioselective C‐H Amination of N ‐Pyridyl Imines Using Azidotrimethylsilane and TBHP: A One‐Pot, Domino Approach to Substituted Imidazo[4, 5‐b]pyridines
inferred← citeshttps://doi.org/10.1002/slct.202004584openalex-snapshot
Synthesis and Cytotoxicity of Some Imidazo[4,5‐ b ]pyridine Derivatives and Their Regioselective N ‐Alkylation
inferred← citeshttps://doi.org/10.1002/slct.202200455openalex-snapshot
Design, and Synthesis of Aryl Derivatives of Imidazopyridine‐Thiadiazoles as Possible Anticancer Agents
inferred← citeshttps://doi.org/10.1002/slct.202204774openalex-snapshot
Synthesis of New 2‐(Pyridin‐4‐yl)‐1H‐imidazo[4,5‐ b ]pyridine Derivatives: In vitro Antibacterial and In silico Screening
inferred← citeshttps://doi.org/10.1007/978-981-16-8399-2_7openalex-snapshot
Overview on Biological Activities of Pyrazole Derivatives
inferred← citeshttps://doi.org/10.1007/s10593-015-1765-7openalex-snapshot
Synthesis and potent cytotoxicity of some novel imidazopyridine derivatives against MCF-7 human breast adenocarcinoma cell line
inferred← citeshttps://doi.org/10.1007/s11030-026-11537-yopenalex-snapshot
Exploration of a Novel Imidazo[4,5-b]pyridine–dihydropyrimidinone hybrids as aurora kinase a inhibitors: integrated pharmacophore modelling, docking and simulation approaches
inferred← citeshttps://doi.org/10.1007/s41061-024-00459-8openalex-snapshot
Reaction Pattern and Mechanistic Aspects of Iodine and Iodine-Based Reagents in Selenylation of Aliphatic, Aromatic, and (Hetero)Cyclic Systems
inferred← citeshttps://doi.org/10.1016/b978-0-08-096807-0.00012-9openalex-snapshot
Six-Membered Ring Systems: Pyridine and Benzo Derivatives
inferred← citeshttps://doi.org/10.1016/b978-0-08-099406-2.00006-6openalex-snapshot
Six-Membered Ring Systems
inferred← citeshttps://doi.org/10.1016/b978-0-12-818655-8.00021-4openalex-snapshot
Bicyclic 5-6 Systems: Three Heteroatoms 2:1
inferred← citeshttps://doi.org/10.1016/b978-0-323-91287-7.00028-4openalex-snapshot
Aurora kinase: An emerging potential target in therapeutics
inferred← citeshttps://doi.org/10.1016/bs.aihch.2017.12.001openalex-snapshot
Recent Developments in the Chemistry of 1,2,3-Thiadiazoles
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104502openalex-snapshot
Synthesis, biological properties and structural study of new halogenated azolo[4,5-b]pyridines as inhibitors of CK2 kinase
inferred← citeshttps://doi.org/10.1016/j.bioorg.2023.106831openalex-snapshot
Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review
inferred← citeshttps://doi.org/10.1016/j.bioorg.2023.106901openalex-snapshot
A novel class of pyrazole analogues as aurora kinase A inhibitor: design, synthesis, and anticancer evaluation
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.08.003openalex-snapshot
7-(Pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine-based derivatives for kinase inhibition: Co-crystallisation studies with Aurora-A reveal distinct differences in the orientation of the pyrazole N1-substituent
inferred← citeshttps://doi.org/10.1016/j.cdc.2020.100608openalex-snapshot
Design, synthesis and biological evaluation of sulphonamide derivatives of benzofuran-imidazopyridines as anticancer agents
inferred← citeshttps://doi.org/10.1016/j.cdc.2026.101265openalex-snapshot
Design, synthesis and biological evaluation of chalcone derivatives of imidazo[4,5-b]pyridines as anticancer agents
inferred← citeshttps://doi.org/10.1016/j.chembiol.2015.12.005openalex-snapshot
The Intersection of Structural and Chemical Biology - An Essential Synergy
inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.07.108openalex-snapshot
Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.04.077openalex-snapshot
The therapeutic voyage of pyrazole and its analogs: A review
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.06.002openalex-snapshot
Dual FLT3 inhibitors: Against the drug resistance of acute myeloid leukemia in recent decade
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112108openalex-snapshot
Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112498openalex-snapshot
Recent researches for dual Aurora target inhibitors in antitumor field
inferred← citeshttps://doi.org/10.1016/j.ejps.2019.04.004openalex-snapshot
Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species
inferred← citeshttps://doi.org/10.1016/j.molstruc.2026.146714openalex-snapshot
Synthesis and anticancer evaluation of Thiourea derivatives of structurally modified Imidazo-pyridines: An insight from in-silico molecular docking and molecular dynamic studies
inferred← citeshttps://doi.org/10.1016/j.tetlet.2013.09.086openalex-snapshot
Synthesis of 2-substituted 3-ethyl-3H-imidazo[4,5-b]pyridines catalyzed by Al3+-exchanged K10 clay as solid acids
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01851openalex-snapshot
FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00575openalex-snapshot
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b01261openalex-snapshot
Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.0c00699openalex-snapshot
Natural and Semisynthetic Chalcones as Dual FLT3 and Microtubule Polymerization Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.oprd.0c00515openalex-snapshot
Development of a Robust Scale-Up Synthetic Route for BPR1K871: A Clinical Candidate for the Treatment of Acute Myeloid Leukemia and Solid Tumors
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.8b00364openalex-snapshot
Privileged Structures and Polypharmacology within and between Protein Families
inferred← citeshttps://doi.org/10.1021/acsomega.8b00426openalex-snapshot
Rapid Construction of an Imidazo[4,5- b ]pyridine Skeleton from 2-Chloro-3-nitropyridine via Tandem Reaction in H2O-IPA Medium
inferred← citeshttps://doi.org/10.1021/jm301537popenalex-snapshot
Structure–Activity Relationship Studies of Pyrazolo[3,4-d]pyrimidine Derivatives Leading to the Discovery of a Novel Multikinase Inhibitor That Potently Inhibits FLT3 and VEGFR2 and Evaluation of Its Activity against Acute Myeloid Leukemia in Vitro and in Vivo
inferred← citeshttps://doi.org/10.1021/jm401115gopenalex-snapshot
Aurora Isoform Selectivity: Design and Synthesis of Imidazo[4,5-b]pyridine Derivatives as Highly Selective Inhibitors of Aurora-A Kinase in Cells
inferred← citeshttps://doi.org/10.1039/c3ob27477bopenalex-snapshot
Regioselective C2-arylation of imidazo[4,5-b]pyridines
inferred← citeshttps://doi.org/10.1039/c4cy00112eopenalex-snapshot
K10 montmorillonite clays as environmentally benign catalysts for organic reactions
inferred← citeshttps://doi.org/10.1039/d0ob01904fopenalex-snapshot
Access to 2-pyridinylamide and imidazopyridine from 2-fluoropyridine and amidine hydrochloride
inferred← citeshttps://doi.org/10.1039/d4md00367eopenalex-snapshot
Novel sulfonamides unveiled as potent anti-lung cancer agents via tumor pyruvate kinase M2 activation
inferred← citeshttps://doi.org/10.1039/d6ra01319hopenalex-snapshot
FLT3 inhibitors in AML: from classic scaffolds to next-generation approaches
inferred← citeshttps://doi.org/10.1080/07391102.2021.1997818openalex-snapshot
Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances
inferred← citeshttps://doi.org/10.1080/10406638.2025.2554200openalex-snapshot
Design, Synthesis, Cytotoxicity, and Molecular Docking of New Thiazole Linked Tetrahydropyridine: Pyridine Hybrids
inferred← citeshttps://doi.org/10.1080/1062936x.2016.1228696openalex-snapshot
High-dimensional QSAR modelling using penalized linear regression model withL1/2-norm
inferred← citeshttps://doi.org/10.1080/17460441.2025.2481272openalex-snapshot
Advances in the design, discovery, and optimization of aurora kinase inhibitors as anticancer agents
inferred← citeshttps://doi.org/10.1088/1742-6596/1897/1/012016openalex-snapshot
Quantitative Structure-Activity Relationship Modeling Based on Improving Penalized Linear Regression Model
inferred← citeshttps://doi.org/10.1134/s1070428016120198openalex-snapshot
Design and synthesis of imidazo[4,5-c]pyridine derivatives as promising Aurora kinase A (AURKA) inhibitors
inferred← citeshttps://doi.org/10.1182/bloodadvances.2019000986openalex-snapshot
Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736
inferred← citeshttps://doi.org/10.13005/ojc/380306openalex-snapshot
Pyrazole and Its Derivatives: An Excellent N-Hetrocycle with Wide Range of Biological Applications (A Review)
inferred← citeshttps://doi.org/10.1371/journal.pone.0229801openalex-snapshot
IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models
inferred← citeshttps://doi.org/10.18632/oncotarget.10657openalex-snapshot
Aurora B prevents premature removal of spindle assembly checkpoint proteins from the kinetochore: A key role for Aurora B in mitosis
inferred← citeshttps://doi.org/10.18632/oncotarget.13369openalex-snapshot
Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation
inferred← citeshttps://doi.org/10.2174/1568026614666140929151140openalex-snapshot
Virtual Screening and Discovery of Novel Aurora Kinase Inhibitors
inferred← citeshttps://doi.org/10.2174/1568026623666230714161726openalex-snapshot
Pyrazole; A Privileged Scaffold of Medicinal Chemistry: A Comprehensive Review
inferred← citeshttps://doi.org/10.21873/cdp.10016openalex-snapshot
The Relevance of Aurora Kinase Inhibition in Hematological Malignancies
inferred← citeshttps://doi.org/10.3389/fonc.2013.00170openalex-snapshot
Targeted Drug Discovery for Pediatric Leukemia
inferred← citeshttps://doi.org/10.3389/fonc.2015.00278openalex-snapshot
Aurora Kinase Inhibitors: Current Status and Outlook
inferred← citeshttps://doi.org/10.3390/cancers11111695openalex-snapshot
Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation
inferred← citeshttps://doi.org/10.3390/cancers13010119openalex-snapshot
Dual Kinase Targeting in Leukemia
inferred← citeshttps://doi.org/10.3390/ijms19123987openalex-snapshot
Therapeutic Vulnerabilities in FLT3-Mutant AML Unmasked by Palbociclib
inferred← citeshttps://doi.org/10.3390/molecules21121646openalex-snapshot
A Simple Precursor for Highly Functionalized Fused Imidazo[4,5-b]pyridines and Imidazo[4,5-b]-1,8-naphthyridine
inferred← citeshttps://doi.org/10.3390/molecules23010134openalex-snapshot
Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review
inferred← citeshttps://doi.org/10.3390/molecules25071726openalex-snapshot
Theoretical Studies Aimed at Finding FLT3 Inhibitors and a Promising Compound and Molecular Pattern with Dual Aurora B/FLT3 Activity
inferred← citeshttps://doi.org/10.3390/molecules27248708openalex-snapshot
Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics
inferred← citeshttps://doi.org/10.3998/ark.5550190.p008.131openalex-snapshot
A review of recent progress (2002-2012) on the biological activities of pyrazoles
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.